As stated by GPhA's Board Chairman in 2013, GPhA's mission is "to be on the forefront of increasing access to affordable medicines for all consumers".GPhA 2013 Annual Report Neas and GPhA played a leadership role in protecting the Hatch-Waxman Act;Biopharma Dive, February 5, 2015, Nicole Gray, "Passing the Torch: Ralph Neas' Tenure at GPhA"; GPhA 2012 Annual Report enacting the Generic Drug User Fees Act;Journal of Generic Medicines, Summer, 2012, "A Global Future for Biosimilars"; San Jose Mercury News, Neas op-ed promoting and defending biosimilars at the national and state levels;October 4, 2013, "Biosimilars: Jerry Brown Should Veto Bill that Protects Big Biotech Profits" ; New York Times, Andrew Pollack, October 13, 2013, "Governor Brown of Cal. Vetoes Biotech Drug Bill" and making sure that international trade agreements did not favor manufacturers of brand medicines and biologics;The Hill, January 28, 2015, "Trans Pacific Partnership: Ambitious Enough?"; Huffington Post, July 29, 2015, Neas op-ed with Nancy Leamond, AARP, "TPP Threatens Access to Affordable Medicine for People Around the World"; Statement of Ralph G. Neas, opposing pharmaceutical exclusivity provisions of the TPP, press conference with Doctors Without Borders, AARP, AFL-CIO, and Oxfam, December 17, 2015; 2015 GPhA Annual Report
